Repurposing FDA-approved drugs may help combat COVID-19
The Pharma Data
FEBRUARY 25, 2022
. “The SARS-CoV-2 vaccines target the spike protein, but this protein is under strong selection pressure and, as we have seen with Omicron, can undergo significant mutations,” said Joyce Jose, assistant professor of biochemistry and molecular biology, Penn State. 25) in the journal Communications Biology. .
Let's personalize your content